TY - JOUR
T1 - Approach to Common Sleep Disorders
AU - Wang, Yujie
AU - Salas, Rachel Marie E.
N1 - Funding Information:
R.M.E.S. reports grants from Macy Foundation, personal fees from UpToDate, and grants from AMA innovation grant, outside the submitted work.
Publisher Copyright:
© 2021 Royal Society of Chemistry. All rights reserved.
PY - 2021/12/1
Y1 - 2021/12/1
N2 - Sleep disorders are highly relevant in clinical practice given their prevalence as well as their impact on health outcomes and quality of life. The most common concerns are excessive daytime sleepiness, insomnia, disordered breathing, and abnormal movements or behaviors during sleep. A detailed but targeted history is vital, particularly from the sleep partner/witness. In-laboratory sleep testing (polysomnography and multiple sleep latency test) remains vital in the diagnosis of certain sleep disorders (such as sleep-disordered breathing and central hypersomnia) and in specific populations (such as in children and individuals with comorbid medical disorders). Advances in technology have allowed for a variety of methods in assessing a patient's sleep, from compact devices to evaluate for sleep apnea, wrist actigraphy, and mobile device-based applications. As the pathophysiology of various sleep disorders becomes better elucidated, disease-specific medications have been developed for these conditions. Nonetheless, a multidisciplinary approach to management is necessary, including improving sleep hygiene and cognitive behavioral therapy.
AB - Sleep disorders are highly relevant in clinical practice given their prevalence as well as their impact on health outcomes and quality of life. The most common concerns are excessive daytime sleepiness, insomnia, disordered breathing, and abnormal movements or behaviors during sleep. A detailed but targeted history is vital, particularly from the sleep partner/witness. In-laboratory sleep testing (polysomnography and multiple sleep latency test) remains vital in the diagnosis of certain sleep disorders (such as sleep-disordered breathing and central hypersomnia) and in specific populations (such as in children and individuals with comorbid medical disorders). Advances in technology have allowed for a variety of methods in assessing a patient's sleep, from compact devices to evaluate for sleep apnea, wrist actigraphy, and mobile device-based applications. As the pathophysiology of various sleep disorders becomes better elucidated, disease-specific medications have been developed for these conditions. Nonetheless, a multidisciplinary approach to management is necessary, including improving sleep hygiene and cognitive behavioral therapy.
KW - insomnia
KW - narcolepsy
KW - obstructive sleep apnea
KW - restless legs syndrome
KW - sleep disorders
UR - http://www.scopus.com/inward/record.url?scp=85120556325&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85120556325&partnerID=8YFLogxK
U2 - 10.1055/s-0041-1726364
DO - 10.1055/s-0041-1726364
M3 - Article
C2 - 34826879
AN - SCOPUS:85120556325
SN - 0271-8235
VL - 41
SP - 781
EP - 794
JO - Seminars in neurology
JF - Seminars in neurology
IS - 6
ER -